Baishan Wu1, Li Yue2, Fenglong Sun3, Shan Gao4, Bing Liang5, Tao Tao6,7. 1. Department of Pain Management, Xuanwu Hospital, Capital Medical University, Beijing, China. 2. Department of Anesthesiology, Changzhou Tumor Hospital, Changzhou, Jiangsu, China. 3. Department of Orthopedics, Beijing Rehabilitation Hospital Affiliated to Capital Medical University, Capital Medical University, Beijing, China. 4. Department of Acupuncture & Moxibustion, Wuhan Hospital of Integrated Chinese & Western Medicine, Tongji Medical College of Huazhong University of Science & Technology, Wuhan, Hubei, China. 5. Department of Anesthesiology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China. 6. Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 7. Department of Anesthesiology, Central People's Hospital of Zhanjiang, Zhanjiang, China.
Abstract
OBJECTIVE: The cervicogenic headache is a syndrome caused by dysfunction of the upper cervical spine and its component bony, disc, and/or soft tissue elements. The C2 nerve root may play a pivotal role in cervicogenic headache. In this retrospective study, we evaluated the feasibility and efficacy of ultrasound-guided C2 nerve root coblation in managing 26 patients with cervicogenic headache. DESIGN AND SETTING: The data were collected retrospectively by reviewing the patient's medical records and pain questionnaires. SUBJECTS AND METHODS: A total of 109 patients with cervicogenic headache sustained for at least six months were identified. Of those patients, 26 had a visual analog scale score ≥6 and subsequently underwent an ultrasound-guided C2 nerve root coblation. RESULTS: All 26 patients had >50% pain relief one day after coblation. Twenty-three of the 26 patients (92.31%) had a decrease in their pain score of 50% or more at 24-week follow-up. The mean pain score was 7.38 ± 1.13 before coblation and 1.85 ± 0.83 one day after coblation (Bonferroni-adjusted P < 0.001). At 12 and 24 weeks after coblation, the mean pain scores were 2.96 ± 0.96 (P < 0.001) and 3.08 ± 1.38 (P < 0.008), respectively. CONCLUSIONS: C2 nerve coblation may provide the majority of patients with a pain relief period as long as 24 weeks. And ultrasound guidance is an efficient method with which to perform coblation.
OBJECTIVE: The cervicogenic headache is a syndrome caused by dysfunction of the upper cervical spine and its component bony, disc, and/or soft tissue elements. The C2 nerve root may play a pivotal role in cervicogenic headache. In this retrospective study, we evaluated the feasibility and efficacy of ultrasound-guided C2 nerve root coblation in managing 26 patients with cervicogenic headache. DESIGN AND SETTING: The data were collected retrospectively by reviewing the patient's medical records and pain questionnaires. SUBJECTS AND METHODS: A total of 109 patients with cervicogenic headache sustained for at least six months were identified. Of those patients, 26 had a visual analog scale score ≥6 and subsequently underwent an ultrasound-guided C2 nerve root coblation. RESULTS: All 26 patients had >50% pain relief one day after coblation. Twenty-three of the 26 patients (92.31%) had a decrease in their pain score of 50% or more at 24-week follow-up. The mean pain score was 7.38 ± 1.13 before coblation and 1.85 ± 0.83 one day after coblation (Bonferroni-adjusted P < 0.001). At 12 and 24 weeks after coblation, the mean pain scores were 2.96 ± 0.96 (P < 0.001) and 3.08 ± 1.38 (P < 0.008), respectively. CONCLUSIONS: C2 nerve coblation may provide the majority of patients with a pain relief period as long as 24 weeks. And ultrasound guidance is an efficient method with which to perform coblation.